Literature DB >> 18065161

Assessment of cocaine and other drug dependence in the general population: "gated" versus "ungated" approaches.

Louisa Degenhardt1, Kipling M Bohnert, James C Anthony.   

Abstract

BACKGROUND: There is a need for large-scale epidemiological surveys to be (a) faithful to diagnostic specifications and (b) constrain time and participant burden associated with each section of a possibly lengthy interview.
OBJECTIVE: To examine whether one "gating" approach devised for recent large-scale international psychiatric surveys results in a reduced number of identified cases of drug dependence and/or biases in estimated associations with background characteristics. DESIGN AND
SETTING: Data from a recently released cross-sectional, nationally representative household survey, the United States National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) were analysed. PARTICIPANTS: Forty-three thousand ninety-three English speaking adults aged 18 years and over. MAIN OUTCOME MEASURES: Dependence upon cocaine and other illegal drug dependence, defined in two ways: "ungated" and "gated". "Ungated" dependence included all persons meeting criteria for DSM-IV dependence, without regard for DSM-IV drug abuse clinical features. "Gated" dependence required at least one feature of DSM-IV drug abuse.
RESULTS: There was no statistically robust decrement in the estimated prevalence of cocaine or other drug dependence using a "gated" assessment. Patterns of association of cocaine dependence with background characteristics were not appreciably different when the gated and ungated approaches were applied.
CONCLUSIONS: In panoramic mental health surveys, the inefficiency of an ungated approach must be balanced against the anticipated number of cases of dependence without associated social role impairments or harm. In this study, the reduction in the number of identified cocaine dependence cases appeared to be so small that even in a sample of over 40,000 participants, attenuation in population prevalence would prove difficult to detect.

Entities:  

Mesh:

Year:  2007        PMID: 18065161      PMCID: PMC2756072          DOI: 10.1016/j.drugalcdep.2007.09.024

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  19 in total

1.  Controversies in community-based psychiatric epidemiology: let the data speak for themselves.

Authors:  D G Blazer
Journal:  Arch Gen Psychiatry       Date:  2000-03

2.  Limitations of the application of fourfold table analysis to hospital data.

Authors:  J BERKSON
Journal:  Biometrics       Date:  1946-06       Impact factor: 2.571

3.  "Clinical significance" and DSM-IV.

Authors:  H A Pincus; D A Zarin; M First
Journal:  Arch Gen Psychiatry       Date:  1998-12

4.  Diagnosis and need for treatment are not the same.

Authors:  R L Spitzer
Journal:  Arch Gen Psychiatry       Date:  1998-02

5.  Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates.

Authors:  William E Narrow; Donald S Rae; Lee N Robins; Darrel A Regier
Journal:  Arch Gen Psychiatry       Date:  2002-02

6.  Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia.

Authors:  E Robins; S B Guze
Journal:  Am J Psychiatry       Date:  1970-01       Impact factor: 18.112

Review 7.  Limitations of diagnostic criteria and assessment instruments for mental disorders. Implications for research and policy.

Authors:  D A Regier; C T Kaelber; D S Rae; M E Farmer; B Knauper; R C Kessler; G S Norquist
Journal:  Arch Gen Psychiatry       Date:  1998-02

8.  The co-occurrence of DSM-IV alcohol abuse in DSM-IV alcohol dependence: results of the National Epidemiologic Survey on Alcohol and Related Conditions on heterogeneity that differ by population subgroup.

Authors:  Deborah S Hasin; Bridget F Grant
Journal:  Arch Gen Psychiatry       Date:  2004-09

9.  A recent decline in cocaine use among youthful arrestees in Manhattan, 1987 through 1993.

Authors:  A Golub; B D Johnson
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

10.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08
View more
  18 in total

1.  Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey.

Authors:  Joel Swendsen; Kevin P Conway; Louisa Degenhardt; Meyer Glantz; Robert Jin; Kathleen R Merikangas; Nancy Sampson; Ronald C Kessler
Journal:  Addiction       Date:  2010-03-10       Impact factor: 6.526

2.  Violations of the usual sequence of drug initiation: prevalence and associations with the development of dependence in the New Zealand Mental Health Survey.

Authors:  J Elisabeth Wells; Magnus A McGee
Journal:  J Stud Alcohol Drugs       Date:  2008-11       Impact factor: 2.582

3.  DSM-5 latent classes of alcohol users in a population-based sample: results from the São Paulo Megacity Mental Health Survey, Brazil.

Authors:  João Mauricio Castaldelli-Maia; Camila M Silveira; Erica R Siu; Yuan-Pang Wang; Igor A Milhorança; Clóvis Alexandrino-Silva; Guilherme Borges; Maria C Viana; Arthur G Andrade; Laura H Andrade; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2014-01-03       Impact factor: 4.492

4.  Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. population.

Authors:  Silvia S Martins; David A Gorelick
Journal:  Drug Alcohol Depend       Date:  2011-12-01       Impact factor: 4.492

Review 5.  The contribution of brain reward circuits to the obesity epidemic.

Authors:  Eric Stice; Dianne P Figlewicz; Blake A Gosnell; Allen S Levine; Wayne E Pratt
Journal:  Neurosci Biobehav Rev       Date:  2012-12-10       Impact factor: 8.989

6.  A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.

Authors:  Frances R Levin; John Mariani; Daniel J Brooks; Martina Pavlicova; Edward V Nunes; Vito Agosti; Adam Bisaga; Maria A Sullivan; Kenneth M Carpenter
Journal:  Addiction       Date:  2013-03-21       Impact factor: 6.526

7.  Cross-national differences in clinically significant cannabis problems: epidemiologic evidence from 'cannabis-only' smokers in the United States, Mexico, and Colombia.

Authors:  Fabian Fiestas; Mirjana Radovanovic; Silvia S Martins; Maria E Medina-Mora; Jose Posada-Villa; James C Anthony
Journal:  BMC Public Health       Date:  2010-03-23       Impact factor: 3.295

8.  Cocaine is low on the value ladder of rats: possible evidence for resilience to addiction.

Authors:  Lauriane Cantin; Magalie Lenoir; Eric Augier; Nathalie Vanhille; Sarah Dubreucq; Fuschia Serre; Caroline Vouillac; Serge H Ahmed
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

9.  Further evidence of differences in substance use and dependence between Australia and the United States.

Authors:  Orla McBride; Maree Teesson; Tim Slade; Deborah Hasin; Louisa Degenhardt; Andrew Baillie
Journal:  Drug Alcohol Depend       Date:  2008-11-29       Impact factor: 4.492

10.  Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits.

Authors:  M D Glantz; J C Anthony; P A Berglund; L Degenhardt; L Dierker; A Kalaydjian; K R Merikangas; A M Ruscio; J Swendsen; R C Kessler
Journal:  Psychol Med       Date:  2008-12-02       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.